{
    "2018-04-24": [
        [
            {
                "time": "2018-01-01",
                "original_text": "Tresiba Could Significantly Drive Novo Nordiskâ€™s Revenue in 2018",
                "features": {
                    "keywords": [
                        "Tresiba",
                        "Significantly Drive",
                        "Novo Nordisk",
                        "Revenue"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-01",
                "original_text": "Ozempic Could Be Potential Driver for Novo Nordisk in 2018",
                "features": {
                    "keywords": [
                        "Ozempic",
                        "Potential Driver",
                        "Novo Nordisk"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-01",
                "original_text": "This Small Biotech Is Building on a Surprising Success",
                "features": {
                    "keywords": [
                        "Small Biotech",
                        "Building",
                        "Surprising Success"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}